» Articles » PMID: 37238445

Translating Precision Health for Pediatrics: A Scoping Review

Overview
Specialty Health Services
Date 2023 May 27
PMID 37238445
Authors
Affiliations
Soon will be listed here.
Abstract

Precision health aims to personalize treatment and prevention strategies based on individual genetic differences. While it has significantly improved healthcare for specific patient groups, broader translation faces challenges with evidence development, evidence appraisal, and implementation. These challenges are compounded in child health as existing methods fail to incorporate the physiology and socio-biology unique to childhood. This scoping review synthesizes the existing literature on evidence development, appraisal, prioritization, and implementation of precision child health. PubMed, Scopus, Web of Science, and Embase were searched. The included articles were related to pediatrics, precision health, and the translational pathway. Articles were excluded if they were too narrow in scope. In total, 74 articles identified challenges and solutions for putting pediatric precision health interventions into practice. The literature reinforced the unique attributes of children and their implications for study design and identified major themes for the value assessment of precision health interventions for children, including clinical benefit, cost-effectiveness, stakeholder values and preferences, and ethics and equity. Tackling these identified challenges will require developing international data networks and guidelines, re-thinking methods for value assessment, and broadening stakeholder support for the effective implementation of precision health within healthcare organizations. This research was funded by the SickKids Precision Child Health Catalyst Grant.

Citing Articles

Exploring perceived barriers and attitudes in young adults towards antidepressant pharmacotherapy, including the implementation of pharmacogenetic testing to optimize prescription practices.

Roberts B, Cooper Z, Landery G, Stanley S, Majda B, Collins K Front Pharmacol. 2025; 15():1526101.

PMID: 39830342 PMC: 11739104. DOI: 10.3389/fphar.2024.1526101.


Precision prevention in occupational health: a conceptual analysis and development of a unified understanding and an integrative framework.

Mess F, Blaschke S, Gebhard D, Friedrich J Front Public Health. 2024; 12:1444521.

PMID: 39360261 PMC: 11445082. DOI: 10.3389/fpubh.2024.1444521.

References
1.
Vijverberg S, Pijnenburg M, Hovels A, Koppelman G, der Zee A . The need for precision medicine clinical trials in childhood asthma: rationale and design of the PUFFIN trial. Pharmacogenomics. 2017; 18(4):393-401. DOI: 10.2217/pgs-2016-0174. View

2.
Dagar A, Cherlopalle S, Ahuja V, Senko L, Butler R, Austerman J . Real-world experience of using combinatorial pharmacogenomic test in children and adolescents with depression and anxiety. J Psychiatr Res. 2021; 146:83-86. DOI: 10.1016/j.jpsychires.2021.12.037. View

3.
Rawson N . Health technology assessment and price negotiation alignment for rare disorder drugs in Canada: Who benefits?. Orphanet J Rare Dis. 2022; 17(1):218. PMC: 9190095. DOI: 10.1186/s13023-022-02390-x. View

4.
Cohn I, Manshaei R, Liston E, Okello J, Khan R, Curtis M . Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting. JAMA Netw Open. 2021; 4(5):e2110446. PMC: 8155824. DOI: 10.1001/jamanetworkopen.2021.10446. View

5.
Fernandes B, Williams L, Steiner J, Leboyer M, Carvalho A, Berk M . The new field of 'precision psychiatry'. BMC Med. 2017; 15(1):80. PMC: 5390384. DOI: 10.1186/s12916-017-0849-x. View